Please circulate this announcement in your lab

March 21st 2019, 13h30-15h00
Bordeaux Pellegrin Hospital, Imagerie Service, 1st floor

Andreas Bergthaler (Viral Diseases & Inflammation, CeMM, Vienna)

"Infection Associated Cachexia - Boon or Bane?"

A TransBioMed and PhilInBioMed seminar

Open to all
 
Cachexia is thought to be a leading cause of morbidity and mortality in various 
cancers, chronic inflammation and infections. Our understanding of the 
mechanisms driving cachexia remains limited, especially in the case of 
infection-associated cachexia (IAC). I will discuss my laboratory`s recent 
investigations about a reversible course of cachexia during chronic viral 
infection and the identification of an essential role for CD8 T cells in IAC 
(Baazim et al. Nature Immunology, in press). Cytokines implicated in 
cancer-associated cachexia do not contribute to IAC. Instead, we found that 
virus-specific CD8 T cells cause morphological and molecular changes in adipose 
tissue leading to depleted lipid stores. These changes occur at a time point 
preceding the peak of CD8 T cell response and require T cell-intrinsic type I 
interferon signaling and antigen-specific priming. Our results link systemic 
antiviral immune responses to adipose tissue remodeling and reveal an 
underapprecia
 ted role of CD8 T cells in IAC. While cachexia in terminal cancer is generally 
considered to be detrimental to the patient, we hypothesise that cachexia in 
the context of infections may represent an evolutionary-conserved response 
program to nurture the host`s immune response and to ameliorate the course of 
disease.Further information on the seminar here.
 
Andreas Bergthaler is head of the lab Viral Diseases and Inflammation at the 
CeMM – Research Center for Molecular Medicine of the Austrian Academy of 
Sciences, Vienna, Austria and co-founder of the company Hookipa Biotech. His 
research focuses on pathogen-host interactions and viral diseases. Recently he 
published a study in Cancer Cell about the molecular insights into the 
transmissible cancer of Tasmanian devils.
Andreas Bergthaler will be available for individual discussions during his 
stay. Those interested in exchanging with him can sign up here.


Best regards,

Wiebke Bretting
--
Dr. Wiebke Bretting
Project Manager ERC IDEM
ImmunoConcEpT, UMR5164
Université de Bordeaux
146 rue Léo Saignat
33076 Bordeaux
https://www.immuconcept.org/erc-idem/

--
Pour toute question, la FAQ de la liste se trouve ici:  
https://www.vidal-rosset.net/
        
        
        
        
        
        
        
        
        
        
        
        
        
        

Répondre à